Overall we confirm that mutations in known cancer drivers accurately reproduce expected associations with both individual metabolites such as IDH1 mutations and 2‐hydroxyglutarate, and pathways such as KEAP1 mutations and glutathione metabolism. Here, KEAP1 is linked to cancer.